Clinical trial
Study of the Safety and Efficacy of Daily Tenofovir Disoproxil Fumarate for the Prevention of HIV Infection in Heterosexually Active Young Adults in Botswana
NCT00111150 is registered in ClinicalTrials.gov with Centers for Disease Control and Prevention as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of the Safety and Efficacy of Daily Tenofovir Disoproxil Fumarate for the Prevention of HIV Infection in Heterosexually Active Young Adults in Botswana
- Lead sponsor
- Centers for Disease Control and Prevention
- Phase
- Phase 2/3
- Overall status
- Terminated
- Start date
- September 30, 2005
- Completion date
- March 31, 2007
- Enrollment
- 1,200
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
hiv infection